Skip to main content
. 2022 Aug 11;11(16):4702. doi: 10.3390/jcm11164702

Figure 2.

Figure 2

Discriminant Analysis. LTRA therapy discrimination with the number of unplanned specialist visits at time T1 and ΔFeNO 50. FeNO: exhaled nitric oxide; ΔFeNO50: FeNO 50 T0 − FeNO 50 T1. LTRA: leukotriene receptor antagonist. Cross-valid value 66.7%.